share_log

Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities

SEC ·  Nov 30, 2022 16:12
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more